Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice.
We report gene transfer to the Edinburgh insertional mutant mouse (cf/cf), delivering CFTR cDNA-liposome complexes into the airways by nebulization. We show full restoration of cAMP related chloride responses in some animals and demonstrate, in the same tissues, human CFTR cDNA expression. Overall, a range of correction was seen with restoration of about 50% of the deficit between wild type mice and untreated cf/cf controls. We report modest correction in the intestinal tract following direct instillation and provide initial encouraging safety data for both the respiratory and intestinal tract following the liposome mediated gene delivery. The non-viral nature and potentially lower immunogenicity of DNA-liposomes suggest that this may offer a therapeutic alternative to adenoviral therapies.
Alton
E W
EW
Ion Transport Laboratory, National Heart and Lung Institute, London, UK.
Middleton
P G
PG
Caplen
N J
NJ
Smith
S N
SN
Steel
D M
DM
Munkonge
F M
FM
Jeffery
P K
PK
Geddes
D M
DM
Hart
S L
SL
Williamson
R
R
D000818:Animals; D001483:Base Sequence; D001692:Biological Transport / Q000235:genetics; D003550:Cystic Fibrosis / Q000235:genetics / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D018076:DNA, Complementary; D017930:Genes, Reporter; D015316:Genetic Therapy; D006801:Humans; D007422:Intestines; D007477:Ions; D008081:Liposomes; D008565:Membrane Proteins / Q000235:genetics*; D051379:Mice; D008817:Mice, Mutant Strains; D008969:Molecular Sequence Data; D009330:Nebulizers and Vaporizers; D009838:Oligodeoxyribonucleotides
C505032:CFTR protein, human; D018076:DNA, Complementary; D007477:Ions; D008081:Liposomes; D008565:Membrane Proteins; D009838:Oligodeoxyribonucleotides; D019005:Cystic Fibrosis Transmembrane Conductance Regulator